Literature DB >> 7851001

Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management.

G W McCaughan1, R B Feller.   

Abstract

This article reviews osteoporosis (OP) in adults with chronic liver disease. OP in this setting is characterized in general by low bone turnover. The pathogenesis is unclear but is probably not related to vitamin D abnormalities. Patients at high risk of OP include those with evidence of cirrhosis, hypogonadism, overt calcium malabsorption, steroid therapy and choleostatic liver disease (particularly primary biliary cirrhosis). OP is best managed by adequate calcium intake, regular weight bearing exercise, and the avoidance of alcohol and tobacco smoking. There is probably no reason for vitamin D supplementation. Hormonal replacement therapy when necessary is indicated in males and should be considered in females. Finally, liver transplantation has the potential to improve or stabilize OP in the median term, although it is associated with significant short-term deterioration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7851001     DOI: 10.1159/000171456

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  13 in total

1.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

2.  Bone disorders in experimentally induced liver disease in growing rats.

Authors:  Viktória Ferencz; Csaba Horváth; Béla Kári; János Gaál; Szilvia Mészáros; Zsuzsanna Wolf; Dalma Hegedus; Andrea Horváth; Anikó Folhoffer; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 3.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 4.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

5.  Is osteoporosis a peculiar association with primary biliary cirrhosis?

Authors:  Annarosa Floreani; Andrea Mega; Valentina Camozzi; Vincenzo Baldo; Mario Plebani; Patrizia Burra; Giovanni Luisetto
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

6.  Predicting bone loss following orthotopic liver transplantation.

Authors:  O M Crosbie; R Freaney; M J McKenna; M P Curry; J E Hegarty
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

7.  The heterogeneity of bone disease in cirrhosis: a multivariate analysis.

Authors:  Bronwyn A L Crawford; C Kam; A J Donaghy; G W McCaughan
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

8.  Osteoporosis in chronic liver disease: a case-control study.

Authors:  Ghizlane Wariaghli; Aziza Mounach; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2009-07-28       Impact factor: 2.631

9.  Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

Authors:  Ali Gur; Bünyamin Dikici; Kemal Nas; Mehmet Bosnak; Kenan Haspolat; Aysegul Jale Sarac
Journal:  BMC Gastroenterol       Date:  2005-09-19       Impact factor: 3.067

10.  The role of serum cytokines in the pathogenesis of hepatic osteodystrophy in male cirrhotic patients.

Authors:  Ali Riza Soylu; Cengiz Tuglu; Ender Arikan; Tarkan Yetisyigit; Hakan Kunduracılar; Ibrahim Hakki Koker; Gulbin Unsal; Ahmet Huseyin Tezel; Hasan Umit; Sakir Berkarda
Journal:  Gastroenterol Res Pract       Date:  2012-10-14       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.